US20110106235A1 - Method and apparatus for deployment of an endoluminal device - Google Patents

Method and apparatus for deployment of an endoluminal device Download PDF

Info

Publication number
US20110106235A1
US20110106235A1 US12/987,083 US98708311A US2011106235A1 US 20110106235 A1 US20110106235 A1 US 20110106235A1 US 98708311 A US98708311 A US 98708311A US 2011106235 A1 US2011106235 A1 US 2011106235A1
Authority
US
United States
Prior art keywords
sheath
retrograde
endoluminal device
introducer
proximal end
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/987,083
Inventor
Patrick A. Haverkost
Paul F. Choulnard
James Weldon
Karen McDonald
Wade M. Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifeshield Sciences LLC
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to US12/987,083 priority Critical patent/US20110106235A1/en
Publication of US20110106235A1 publication Critical patent/US20110106235A1/en
Assigned to ACACIA RESEARCH GROUP LLC reassignment ACACIA RESEARCH GROUP LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC SCIMED, INC.
Assigned to LIFESHIELD SCIENCES LLC reassignment LIFESHIELD SCIENCES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACACIA RESEARCH GROUP LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • A61F2002/9665Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod with additional retaining means

Definitions

  • This invention relates generally to endoluminal devices and, more specifically, to methods and apparatus for deploying endoluminal devices in body lumens.
  • a stent is an elongated device used to support an intraluminal wall.
  • a stent provides an unobstructed conduit through a body lumen in the area of the stenosis.
  • Such a stent may also have a prosthetic graft layer of fabric or covering lining the inside and/or outside thereof.
  • Such a covered stent is commonly referred to in the art as an intraluminal prosthesis, an endoluminal or endovascular graft (EVG), or a stent-graft.
  • EVG endoluminal or endovascular graft
  • a stent-graft may be used, for example, to treat a vascular aneurysm by removing the pressure on a weakened part of an artery so as to reduce the risk of rupture.
  • stent may have similar structures to stents and may be placed in a body lumen by similar methods.
  • endoluminal device refers to covered and uncovered stents, filters, and any other device that may be placed in a lumen.
  • stent as used herein is a shorthand reference referring to a covered or uncovered stent.
  • an endoluminal device such as a stent-graft deployed in a blood vessel at the site of a stenosis or aneurysm
  • an endoluminal device is implanted endoluminally, i.e. by so-called “minimally invasive techniques” in which the device, restrained in a radially compressed configuration by a sheath or catheter, is delivered by a delivery system or “introducer” to the site where it is required.
  • the introducer may enter the body from an access location outside the body, such as through the patient's skin, or by a “cut down” technique in which the entry blood vessel is exposed by minor surgical means.
  • proximal refers to portions of the stent or delivery system relatively closer to this access location, whereas the term “distal” is used to refer to portions farther from the access location.
  • the introducer When the introducer has been threaded into the body lumen to the stent deployment location, the introducer is manipulated to cause the stent to be ejected from the surrounding sheath or catheter in which it is restrained (or alternatively the surrounding sheath or catheter is retracted from the stent), whereupon the stent expands to a predetermined diameter at the deployment location, and the introducer is withdrawn.
  • Stent expansion may be effected by spring elasticity, balloon expansion, or by the self-expansion of a thermally or stress-induced return of a memory material to a pre-conditioned expanded configuration.
  • a standard pre-loaded delivery system 10 comprising an outer sheath 12 , a compressed endoluminal device 14 loaded therein, and a conventional stabilizer 16 loaded adjacent to the proximal end 17 of the endoluminal device.
  • a standard deployment technique comprises maneuvering the introducer to a desired deployment location and retracting outer sheath 12 so that the endoluminal device is deployed beginning at its distal end and ending at its proximal end.
  • Stabilizer 16 stabilizes or prevent retraction of endoluminal device 14 when sheath 12 is retracted, thus effecting deployment of the device into a desired location by forcing relative movement between the sheath and the device.
  • Delivery system 10 also may comprise a catheter tip 20 at its distal end attached to an internal shaft 23 that runs through the delivery system through inner lumen 22 in stabilizer 16 , as shown in FIG. 1A .
  • a stabilizer handle 26 is typically located at the proximal end of stabilizer 16 , outside the body lumen.
  • Internal shaft 23 may guide the delivery system through the body lumen over a guidewire (not shown) to the area to be repaired, or may be adapted for inflating a balloon (if applicable), and/or for flushing the system.
  • a modular self-expanding stent In a procedure to repair an abdominal aortic aneurysm (AAA), use of a modular self-expanding stent involves accurate placement of a terminus of a first stent component in the abdominal aorta just below the renal arteries. A second stent component is then deployed in the first stent component and permitted to extend to a terminus in one of the iliac arteries. It is difficult, however, to ensure accurate placement of the iliac terminus of the second stent component. If the terminus is not placed far enough into the iliac, then the stent may be ineffective. If the terminus extends too far, it may interfere with blood flow in arteries branching from the iliac, such as the internal iliac artery. This problem also occurs in the deployment of multipart stents in other branched arteries. Thus, it is desirable to provide a way to ensure accurate deployment of all the termini of a multipart stent.
  • an introducer having a retrograde portion and an anterograde portion for deployment of an endoluminal device in a distal location from a proximal location.
  • the introducer comprises, in a most basic embodiment, a shaft having a distal tip; an inner sheath mounted concentrically over the shaft with the endoluminal device mounted concentrically over the inner sheath; and an anterograde sheath attached proximally to the distal tip, mounted over the endoluminal device in the anterograde portion of the introducer, and axially moveable relative to the inner sheath by moving the shaft.
  • the introducer may further comprise anchoring means in at least one of the retrograde portion or the anterograde portion for anchoring the endoluminal device during deployment of the device from its proximal end to its distal end.
  • the anchoring means comprises an inflatable balloon in the retrograde portion.
  • a proximally retractable retrograde sheath may be mounted concentrically over the shaft and inner sheath and may extend axially over the proximal end of the endoluminal device and the balloon.
  • a medial sheath may be mounted concentrically between the inner sheath and the retrograde sheath in the retrograde portion of the introducer proximal the balloon.
  • the anchoring means comprises a holder in the anterograde portion.
  • the holder may be concentrically mounted to the inner sheath and adapted to prevent distal movement of the endoluminal device during advancement of the anterograde shaft.
  • the anterograde sheath may extend over an entire length of the endoluminal device.
  • the introducer comprises the proximally retractable retrograde sheath and the medial sheath
  • the anchoring means comprises an extended portion of a proximal end of the endoluminal device and a notch in one or both of the medial sheath and the retrograde sheath for releasably confining the extended portion between the retrograde sheath and the medial sheath with the retrograde sheath in a first position and for releasing the extended portion with the retrograde sheath in a second, retracted position relative to the medial sheath.
  • the anchoring means comprises a tether attached to a proximal end of the endoluminal device.
  • the tether may be attached to one of the medial sheath, the retrograde sheath, or the inner sheath.
  • the tether may extend proximally from the device a sufficient distance to terminate outside a body lumen through which the introducer is adapted to be introduced.
  • the medial sheath may comprise a lateral channel through which the tether extends.
  • Still another embodiment of the present invention comprises an introducer having a retrograde portion and an anterograde portion and comprising an inflatable balloon mounted radially inside the retrograde portion for anchoring the endoluminal device during deployment of the device from its proximal end to its distal end.
  • the anterograde portion comprises a distal tip and an anterograde sheath attached proximally to the distal tip.
  • a shaft attached to the distal tip and extending concentrically through a central lumen defined by the anterograde portion and retrograde portion is adapted for moving the anterograde portion relative to the retrograde portion.
  • the endoluminal device is mounted concentrically over the shaft in the central lumen and has a distal end contained by the anterograde portion and a proximal end contained by the retrograde portion.
  • the introducer may further comprise an inner sheath mounted concentrically over the shaft underneath the endoluminal device, the inner sheath defining a lumen connected to an inner region of the inflatable balloon for communication of a fluid to the balloon for inflation of the balloon.
  • the retrograde portion comprises a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath and extending distally over the balloon and a retrograde portion of the endoluminal device.
  • the invention also comprises a method for deployment of an endoluminal device in a distal location in a body lumen from a proximal location.
  • the method comprises the steps of inserting an introducer of the present invention into a body lumen, aligning the introducer in a deployment location, extending the shaft to distally advance the anterograde sheath to deploy at least the anterograde portion of the endoluminal device, and then removing the introducer from the body lumen.
  • the introducer comprises anchoring means in the anterograde portion
  • the method comprises aligning the proximal end of the device with the deployment location, and confining the endoluminal device between the anchoring means and the advancing anterograde sheath during advancement of the anterograde sheath.
  • the anchoring means are in the retrograde portion, the method comprises anchoring the proximal end during advancement of the anterograde sheath and releasing the proximal end prior to or concurrently with removal of the introducer from the lumen
  • the method comprises inflating the balloon prior to deployment of the anterograde portion of the endoluminal device and deflating the balloon after deployment of the anterograde portion.
  • the retrograde sheath may be retracted prior to inflating the balloon, such that the balloon is inflated to anchor the proximal end of the endoluminal device against the body lumen.
  • the balloon may be inflated to anchor the proximal end of the endoluminal device against the retrograde sheath, in which case the retrograde sheath is not retracted until after deflating the balloon after the anterograde portion of the endoluminal device has been deployed.
  • the method comprises separating the tether from the endoluminal device prior to or during removal of the introducer from the body.
  • the anchoring means comprises an extended portion of the endoluminal device releasably confined in a notch between the retrograde sheath and the medial sheath or between the retrograde sheath and the inner sheath
  • the method comprises retracting the retrograde sheath sufficient to release the extended portion from the notch after deployment of the anterograde portion of the endoluminal device.
  • an exemplary method comprises aligning the introducer in a deployment location, retracting at least part of the retrograde portion and deploying the proximal end of the endoluminal device.
  • the balloon is then inflated to compress the endoluminal device against the lumen wall while the shaft is extended to distally advance the anterograde sheath to deploy a remaining portion of the endoluminal device.
  • FIG. 1A shows a longitudinal section of a standard introducer of the prior art
  • FIG. 1B shows a detailed longitudinal section of the encircled portion of FIG. 1A ;
  • FIG. 2 shows a longitudinal section of an exemplary introducer of the present invention
  • FIG. 3 shows a flowchart depicting an exemplary method of the invention
  • FIG. 4A shows a longitudinal section of a portion of an exemplary introducer of the present invention having an extended cell and notch anchoring arrangement and a medial sheath;
  • FIG. 4B shows a longitudinal section of a portion of another exemplary introducer of the present invention having an extended cell and notch anchoring arrangement with no medial sheath;
  • FIG. 5A shows a longitudinal section of a portion of an exemplary introducer of the present invention having a tether attached to the retrograde sheath for anchoring the proximal end of the endoluminal device;
  • FIG. 5B shows a cross section of a portion of another embodiment of an exemplary introducer of the present invention having a channel in the medial sheath for the tether;
  • FIG. 5C shows a longitudinal section of a portion of another exemplary introducer embodiment of the present invention having a tether attached to the inner sheath for anchoring the proximal end of the endoluminal device;
  • FIG. 6 shows a longitudinal section of another exemplary introducer of the present invention having a holder at the distal end of the endoluminal device
  • FIG. 7 shows a portion of a longitudinal section of another exemplary introducer of the present invention in which the balloon is contained within the retrograde portion.
  • Introducer 100 comprises a retrograde portion 102 and an anterograde portion 104 .
  • Shaft 106 may be solid or tubular, and is surrounded by three concentrically positioned sheaths: inner sheath 108 , medial sheath 110 , and retrograde sheath 112 .
  • Medial sheath 110 preferably has a fixed position and operates as a radial spacer, separating retrograde sheath distal extension 114 from inner sheath distal extension 116 .
  • the distal extension 114 of retrograde sheath 112 and distal extension 116 of inner sheath 108 comprise the respective portions of those sheaths located distally of the distal end 111 of medial sheath 110 .
  • inner sheath or retrograde sheath may provide such spacing.
  • inner sheath may have a stepped outside diameter or retrograde sheath may have a stepped inside diameter, such as created by medial sheath being fused to either inner sheath or retrograde sheath, or by any other method that creates an equivalent structure.
  • Radial space 118 between retrograde sheath 112 and inner sheath 108 may be sufficiently large to allow room for a radial-force-exerting device, such as balloon 120 .
  • Inner sheath 108 preferably has a fixed position and may include a lumen for communicating pressurized fluid to balloon 120 .
  • balloon 120 and proximal end 131 of device 130 may be part of anterograde portion 104 and covered by anterograde sheath 126 .
  • Anterograde portion 104 of introducer 100 includes a distal extension 122 of shaft 106 and distal extension 116 of inner sheath 108 .
  • Distal extension 122 of shaft 106 terminates with an attachment to radial spacer 125 connected to distal tip 124 .
  • Distal tip 124 is coupled to anterograde sheath 126 , which extends proximally from distal tip 124 , and is positioned concentrically about shaft distal extension 122 and inner sheath distal extension 116 .
  • Radial spacer 125 creates an area 128 into which an endoluminal device 130 , such as a stent graft, can be loaded.
  • Retrograde sheath 112 and anterograde sheath 126 may have a lateral space 132 therebetween, the sheaths may abut one another (not shown) without any space 132 , or the sheaths may laterally overlap one another as depicted by dashed lines 140 in FIG. 2 .
  • Dashed lines 140 show a proximal extension of anterograde sheath 126 that overlaps retrograde sheath 112 .
  • a similar distal extension (not shown) of retrograde sheath 112 may laterally overlap anterograde sheath 126 .
  • an exemplary method for using introducer 100 is depicted in the flowchart shown in FIG. 3 .
  • the method may be performed, for example, in an operating room or an angiographic suite, preferably under fluoroscopic guidance as is known in the art.
  • the introducer is inserted into a body lumen, as indicated in step 210 , distal tip 124 first, from a proximal access site, such as a femoral artery or iliac artery, for vascular deployment.
  • a proximal access site such as a femoral artery or iliac artery
  • the introducer is threaded into the lumen over a guidewire (not shown) as is well known in the art.
  • the access site may be surgically exposed and punctured with, for example, an 18-gauge needle as is known in the art.
  • proximal end 131 of endoluminal device 130 is aligned in an appropriate deployment position. Fluoroscopic guidance and/or a guide wire may be used to guide proximal end 131 into the desired position.
  • endoluminal device 130 is an AAA stent graft
  • proximal end 131 of device 130 is positioned in the iliac (not shown), preferably just above a branch of the internal iliac artery (not shown).
  • step 230 retrograde sheath 112 is retracted at least far enough to expose proximal end 131 of device 130 and balloon 120 .
  • the anterograde sheath 126 is initially advanced far enough to expose the proximal end and balloon.
  • Balloon 120 is inflated in step 240 , such as by pressurizing balloon 120 with fluid communicated via a lumen in inner sheath 108 , to exert radial force that compresses the retrograde portion 133 of device 130 against the lumen wall (not shown).
  • shaft 106 is extended distally to deploy the anterograde portion 135 of device 130 .
  • the guidewire and retrograde sheath 112 may typically be locked together to prevent movement of the retrograde sheath or the guidewire during extension of the shaft.
  • the “retrograde portion” of device 130 refers to any portion initially covered by the retrograde sheath (as shown in FIG. 2 ) or any portion underlied by balloon 120 and any portion proximal thereof (as shown in FIG. 7 ), and the “anterograde portion” refers to the remainder of the device distal of the retrograde portion.
  • Balloon 120 is then deflated in step 260 and introducer 100 is removed from the lumen in accordance with step 270 . If desired, prior to removal from the lumen, balloon 120 may be used for modeling device 130 to better conform to the contours of the lumen wall, as is known in the art.
  • introducer 100 and the method depicted in FIG. 3 provides means for accurately placing the proximal end of an endoluminal device.
  • step 240 of inflating balloon 120 may be carried out prior to step 230 of retracting retrograde sheath 112 , so that the balloon exerts radial force compressing retrograde portion 133 of device 130 into the retrograde sheath. Then, after step 250 of extending shaft 106 to deploy anterograde portion 135 of device 130 , balloon 120 is deflated in step 260 and retrograde sheath 106 is retracted in step 230 to complete deployment of the retrograde portion of the device. Finally, the introducer is removed in step 270 .
  • the steps are performed in numerical order as shown in FIG.
  • the second method has the advantage that the balloon does not press against the lumen wall, but instead presses against the retrograde sheath, thus avoiding exertion of stress on the lumen wall.
  • This second method is particularly desirable in the case of diseased lumen walls, which could be damaged due to the force of the balloon.
  • This method may sacrifice a few millimeters of accuracy due to recoil of the device 130 . Consequently, the second method may be more desirable for applications in which the small sacrifice in accuracy is medically acceptable.
  • a notch 150 may be located in medial sheath 110 a .
  • a proximally extended portion 131 a of device 130 a such as an extended cell or a loop, is fixed within notch 150 .
  • the retrograde sheath 112 is only retracted in step 230 until the proximal end 131 of stent 130 deploys, except for proximally extended portion 131 a .
  • a radiopaque deployment marker (not shown) may be used to mark the end 131 so that the retrograde sheath is not retracted too far.
  • Steps 240 and 260 are omitted from the method steps, as proximally extended portion 131 a remains compressed in notch 150 between medial sheath 110 a and retrograde sheath 112 to hold the proximal end 131 of device 130 in place until the distal portion of the stent has been deployed. Then, prior to removing deployment device in step 270 , retrograde sheath 112 is retracted the remaining distance necessary to release proximally extended portion 131 a from notch 150 .
  • a tether 152 may be used for anchoring. Distal end 153 of tether 152 is attached to proximal end 131 of device 130 and proximal end 154 of the tether may be attached to the distal end of either retrograde sheath 112 (as shown in FIG. 5A ) or medial sheath 110 (not shown), or to an intermediate portion of inner sheath 108 (shown in FIG. 5C ). Tether 152 may be attached to device 130 and sheath 112 or 110 in any way known in the art, such as by gluing, suturing, stapling, welding, heat shrinking, and the like.
  • the tether may comprise any type of material known in the art, including metal or non-metal filaments.
  • the tether is attached to the device in such a way that it is readily detachable from the device when desired.
  • Suitable mechanism for detachably connecting a wire to an implantable device are described in U.S. Pat. No. 5,354,295 and U.S. Pat. No. 5,122,136 to Guglielmi et al., as well as in U.S. patent application Ser. No. 09/852,524, filed on May 10, 2001, by Chris Elliott on behalf of the assignee of this invention, all of which are incorporated herein by reference.
  • tether 152 may be employed in any way known in the art, including extending proximally all the way back to the access location outside the body lumen.
  • medial sheath 110 a may have a lateral channel running its entire length into which tether 152 may extend.
  • tether 152 may connect to a power supply or a handle for exerting tensional or torsional force, as described in the '524 application.
  • the method is carried out as shown in FIG. 3 up to step 230 , at which point the retrograde sheath 112 is retracted until proximal end 131 of the device 130 deploys, with tether 152 holding proximal end 131 in place.
  • the guidewire is then typically locked with retrograde sheath 112 to prevent further movement of the retrograde sheath 112 , and anterograde sheath 126 is advanced by advancing shaft 106 to deploy the anterograde portion of device 130 .
  • the remainder of retrograde sheath 112 is retracted as part of step 270 to release device 130 from tether 152 .
  • proximal end 154 of tether 152 is attached to medial sheath 110 instead of retrograde sheath 112 , the medial sheath may be retracted, or if the medial sheath is not retractable, the entire introducer may be retracted to release device 130 from tether 152 in step 270 .
  • FIG. 6 Another introducer embodiment 600 is shown in FIG. 6 .
  • all of the components are essentially the same as in embodiment 100 , except that instead of a combination of balloon 120 and retrograde sheath 112 at the proximal end, there is a holder 602 near the distal end of inner sheath extension 116 .
  • Anterograde sheath 126 (and thus anterograde portion 104 of introducer 600 ) extends to the proximal end 131 of device 130 .
  • Holder 602 may comprise any material known in the art and may have any geometry known in the art sufficient to hold device 130 in place while anterograde sheath is advanced. A number of geometries and materials useful for holding a stent in place from inside the stent are described in U.S.
  • holder 602 may be a sleeve of a relatively higher friction material than sheath 126 such that device 130 is frictionally retained while sheath 126 advances.
  • holder 602 may comprise one or more radial protrusions that exerts an axial restraining force against individual members of device 130 .
  • Other structures or combinations of multiple structures may also be used as holders.
  • a holder 602 at or near the distal end of device 130 as shown in FIG. 6 may be beneficial for combination with a balloon at or near the proximal end of the device as shown in FIG. 7 .
  • Such a holder 602 may minimize potential distal advancement of proximal end 131 of device 130 during the initial advancement of sheath 126 to expose balloon 120 , as may otherwise potentially occur as a result of frictional contact between the anterograde sheath and the device.
  • balloon 120 may also be provided with a greater frictional engagement force than sheath 126 so that device 130 tends to stay with the balloon rather than move with the sheath. Such a greater frictional engagement force may be the result of a higher coefficient of friction, for example.
  • the method of using introducer 600 involves steps 210 , 220 , 250 , and 270 , without any of the steps relating to the balloon or the retrograde shaft.
  • the embodiment shown in FIG. 6 may comprise a minimal set of components comprising shaft 106 , inner sheath 108 , holder 602 mounted directly to the inner sheath 108 , and tip 124 attached to anterograde sheath 126 .
  • the remaining components shown in FIG. 6 are optional.
  • Holder 602 is not limited to restraining only the distal end of device 130 .
  • holder 602 may extend the length of device 130 , an embodiment that may be particularly useful with devices having a relatively low column strength.
  • a hybrid of introducers 100 and 600 may also be provided comprising both a holder 602 and a balloon 120 or other anchoring means at proximal end 131 of device 130 , with anterograde sheath 126 extending over the proximal end of the device. In such a configuration comprising a balloon, the deployment method follows the method steps in the order shown in FIG.
  • the method comprises advancing anterograde sheath a sufficient distance to uncover balloon 120 , and then inflating the balloon at step 240 and continuing on with the remainder of the method steps.
  • balloon 120 once inflated, is capable of anchoring device 130 , holder 602 may be located closer to proximal end 131 of the device so that it engages the device only during the initial advancement of anterograde sheath 126 prior to inflation of the balloon.
  • Tethered or extended-portion-and-notch embodiments may also be provided with anterograde sheath 126 extending to the proximal end of endoluminal device 130 .
  • an extended-portion-and-notch embodiment shown in FIG. 4B there may be no medial sheath, such that retrograde sheath 112 a directly contacts inner sheath 108 a , and the notch 150 may be in inner sheath 108 a , retrograde sheath 112 a , or may comprise notch portions 150 a and 150 b in each, respectively, as shown in FIG. 4B .
  • the medial sheath may optionally be present, such as to preserve a constant radial profile throughout the introducer, in which case the notch or a portion of the notch may be located in one or both of the retrograde sheath and the medial sheath.
  • the method of using such an embodiment comprises inserting the device in step 210 , aligning the proximal end in step 220 , extending the shaft to deploy the device 250 , and then retracting the retrograde sheath in step 230 a sufficient distance to release the extended portion from the notch.
  • tether 152 may just be attached to an intermediate portion of inner sheath 108 as shown in FIG. 5C , or may extend freely (not shown) through the lumen back through the access location and outside the lumen to some means for manipulating the tether, such as the means shown and described in '524 application. As shown in FIG. 5C , tether 152 is wrapped about inner sheath 108 in a manner than fixes it axially and may be further anchored in place with an adhesive.
  • Notch 155 in tether provides a predetermined weak spot so that the retraction of the introducer is sufficient to break the tether at the notch. It is important that the amount of force required to break tether 152 at a preferred location, such as notch 155 , is less than the amount of force that will break the tether in other locations or remove the affixation of the tether to inner sheath, more than the amount of force necessary to hold proximal end 131 of endoluminal device 130 in place during deployment of its distal end (so that it does not break prematurely), and less than the amount of force that will axially move device 130 once deployed in the lumen (so that breaking the tether does not take the deployed device out of its proper alignment).
  • the tether may also be affixed in a slipknot that requires an amount of force to undo the knot that does not break the tether, pull the deployed device out of alignment, or undo prematurely.
  • the dimensions of the introducer may be optimized to prevent damage caused by the anterograde portion being too long.
  • One way of shortening the anterograde portion for a particular application is to lengthen the retrograde portion.
  • anterograde portion and retrograde portions may extend over equal lengths of the device, or portion of the device over which the retrograde portion extends may be longer than the portion over which the anterograde portion extends.
  • Such embodiments for example an introducer wherein the retrograde and anterograde portions extend over equal lengths of the device, may be useful where the location of the proximal end of the device is less important than aligning the middle of the device with a certain region of a lumen.

Abstract

An introducer deploys an endoluminal device in a distal location from a proximal location. The introducer comprises a retrograde portion, an anterograde portion axially moveable relative to the retrograde portion, a shaft having a distal tip and an anterograde sheath attached to the distal tip, and anchoring means in at least one of the retrograde portion or the anterograde portion for anchoring the device during deployment from its proximal end to its distal end. An inner sheath may be mounted concentrically over the shaft with the endoluminal device mounted concentrically over the inner sheath. The anchoring device may comprise an inflatable balloon mounted radially inside the retrograde portion, a tether, or an extended portion of the endoluminal device confined by a notch in the interface of two sheaths in the retrograde portion of the introducer, or may comprise a holder in the anterograde portion.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 11/363,015, filed Feb. 27, 2006, which is a divisional of U.S. application Ser. No. 10/081,641, filed Feb. 22, 2002, the entire contents of which are incorporated herein by reference.
  • TECHNICAL FIELD
  • This invention relates generally to endoluminal devices and, more specifically, to methods and apparatus for deploying endoluminal devices in body lumens.
  • BACKGROUND OF THE INVENTION
  • A stent is an elongated device used to support an intraluminal wall. In the case of a stenosis, a stent provides an unobstructed conduit through a body lumen in the area of the stenosis. Such a stent may also have a prosthetic graft layer of fabric or covering lining the inside and/or outside thereof. Such a covered stent is commonly referred to in the art as an intraluminal prosthesis, an endoluminal or endovascular graft (EVG), or a stent-graft. A stent-graft may be used, for example, to treat a vascular aneurysm by removing the pressure on a weakened part of an artery so as to reduce the risk of rupture. Other devices, such as filters, particularly vena cava filters, may have similar structures to stents and may be placed in a body lumen by similar methods. As used herein, the term “endoluminal device” refers to covered and uncovered stents, filters, and any other device that may be placed in a lumen. The term “stent” as used herein is a shorthand reference referring to a covered or uncovered stent.
  • Typically, an endoluminal device, such as a stent-graft deployed in a blood vessel at the site of a stenosis or aneurysm, is implanted endoluminally, i.e. by so-called “minimally invasive techniques” in which the device, restrained in a radially compressed configuration by a sheath or catheter, is delivered by a delivery system or “introducer” to the site where it is required. The introducer may enter the body from an access location outside the body, such as through the patient's skin, or by a “cut down” technique in which the entry blood vessel is exposed by minor surgical means. The term “proximal” as used herein refers to portions of the stent or delivery system relatively closer to this access location, whereas the term “distal” is used to refer to portions farther from the access location.
  • When the introducer has been threaded into the body lumen to the stent deployment location, the introducer is manipulated to cause the stent to be ejected from the surrounding sheath or catheter in which it is restrained (or alternatively the surrounding sheath or catheter is retracted from the stent), whereupon the stent expands to a predetermined diameter at the deployment location, and the introducer is withdrawn. Stent expansion may be effected by spring elasticity, balloon expansion, or by the self-expansion of a thermally or stress-induced return of a memory material to a pre-conditioned expanded configuration.
  • Referring now to a typical prior art introducer as seen in FIGS. 1A and 1B, there is shown a standard pre-loaded delivery system 10 comprising an outer sheath 12, a compressed endoluminal device 14 loaded therein, and a conventional stabilizer 16 loaded adjacent to the proximal end 17 of the endoluminal device. A standard deployment technique comprises maneuvering the introducer to a desired deployment location and retracting outer sheath 12 so that the endoluminal device is deployed beginning at its distal end and ending at its proximal end. Stabilizer 16 stabilizes or prevent retraction of endoluminal device 14 when sheath 12 is retracted, thus effecting deployment of the device into a desired location by forcing relative movement between the sheath and the device.
  • Delivery system 10 also may comprise a catheter tip 20 at its distal end attached to an internal shaft 23 that runs through the delivery system through inner lumen 22 in stabilizer 16, as shown in FIG. 1A. A stabilizer handle 26 is typically located at the proximal end of stabilizer 16, outside the body lumen. Internal shaft 23 may guide the delivery system through the body lumen over a guidewire (not shown) to the area to be repaired, or may be adapted for inflating a balloon (if applicable), and/or for flushing the system.
  • It is often important during endoluminal device delivery to ensure accurate placement of the device termini, particularly in intravascular deployment of multipart stents. Improper stent placement can prevent successful medical treatment. There is a particular need in the art to anchor the proximal end of a self-expanding stent while deploying the distal end, and also to provide accurate deployment of self-expanding stents in a way that prevents recoil of the endoluminal device upon release, which may adversely affect the accuracy of the device placement. Balloons are commonly used to anchor endoluminal devices during deployment, but the pressure of a balloon against a vessel wall may damage tissue, particularly if the vessel wall is already diseased. Thus, it is further desirable to anchor the proximal end of an endoluminal device while deploying the distal end without applying unnecessary force against the vessel wall.
  • In a procedure to repair an abdominal aortic aneurysm (AAA), use of a modular self-expanding stent involves accurate placement of a terminus of a first stent component in the abdominal aorta just below the renal arteries. A second stent component is then deployed in the first stent component and permitted to extend to a terminus in one of the iliac arteries. It is difficult, however, to ensure accurate placement of the iliac terminus of the second stent component. If the terminus is not placed far enough into the iliac, then the stent may be ineffective. If the terminus extends too far, it may interfere with blood flow in arteries branching from the iliac, such as the internal iliac artery. This problem also occurs in the deployment of multipart stents in other branched arteries. Thus, it is desirable to provide a way to ensure accurate deployment of all the termini of a multipart stent.
  • SUMMARY OF THE INVENTION
  • In accordance with this invention, there is provided an introducer having a retrograde portion and an anterograde portion for deployment of an endoluminal device in a distal location from a proximal location. The introducer comprises, in a most basic embodiment, a shaft having a distal tip; an inner sheath mounted concentrically over the shaft with the endoluminal device mounted concentrically over the inner sheath; and an anterograde sheath attached proximally to the distal tip, mounted over the endoluminal device in the anterograde portion of the introducer, and axially moveable relative to the inner sheath by moving the shaft. The introducer may further comprise anchoring means in at least one of the retrograde portion or the anterograde portion for anchoring the endoluminal device during deployment of the device from its proximal end to its distal end.
  • In one embodiment, the anchoring means comprises an inflatable balloon in the retrograde portion. A proximally retractable retrograde sheath may be mounted concentrically over the shaft and inner sheath and may extend axially over the proximal end of the endoluminal device and the balloon. A medial sheath may be mounted concentrically between the inner sheath and the retrograde sheath in the retrograde portion of the introducer proximal the balloon.
  • In another embodiment, the anchoring means comprises a holder in the anterograde portion. The holder may be concentrically mounted to the inner sheath and adapted to prevent distal movement of the endoluminal device during advancement of the anterograde shaft. The anterograde sheath may extend over an entire length of the endoluminal device.
  • In another embodiment, the introducer comprises the proximally retractable retrograde sheath and the medial sheath, wherein the anchoring means comprises an extended portion of a proximal end of the endoluminal device and a notch in one or both of the medial sheath and the retrograde sheath for releasably confining the extended portion between the retrograde sheath and the medial sheath with the retrograde sheath in a first position and for releasing the extended portion with the retrograde sheath in a second, retracted position relative to the medial sheath.
  • In yet another embodiment, the anchoring means comprises a tether attached to a proximal end of the endoluminal device. In an embodiment comprising the proximally retractable retrograde sheath and the medial sheath, the tether may be attached to one of the medial sheath, the retrograde sheath, or the inner sheath. In another embodiment, the tether may extend proximally from the device a sufficient distance to terminate outside a body lumen through which the introducer is adapted to be introduced. In such an embodiment, the medial sheath may comprise a lateral channel through which the tether extends.
  • Still another embodiment of the present invention comprises an introducer having a retrograde portion and an anterograde portion and comprising an inflatable balloon mounted radially inside the retrograde portion for anchoring the endoluminal device during deployment of the device from its proximal end to its distal end. The anterograde portion comprises a distal tip and an anterograde sheath attached proximally to the distal tip. A shaft attached to the distal tip and extending concentrically through a central lumen defined by the anterograde portion and retrograde portion is adapted for moving the anterograde portion relative to the retrograde portion. The endoluminal device is mounted concentrically over the shaft in the central lumen and has a distal end contained by the anterograde portion and a proximal end contained by the retrograde portion. The introducer may further comprise an inner sheath mounted concentrically over the shaft underneath the endoluminal device, the inner sheath defining a lumen connected to an inner region of the inflatable balloon for communication of a fluid to the balloon for inflation of the balloon. The retrograde portion comprises a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath and extending distally over the balloon and a retrograde portion of the endoluminal device.
  • The invention also comprises a method for deployment of an endoluminal device in a distal location in a body lumen from a proximal location. The method comprises the steps of inserting an introducer of the present invention into a body lumen, aligning the introducer in a deployment location, extending the shaft to distally advance the anterograde sheath to deploy at least the anterograde portion of the endoluminal device, and then removing the introducer from the body lumen. Where the introducer comprises anchoring means in the anterograde portion, the method comprises aligning the proximal end of the device with the deployment location, and confining the endoluminal device between the anchoring means and the advancing anterograde sheath during advancement of the anterograde sheath. Where the anchoring means are in the retrograde portion, the method comprises anchoring the proximal end during advancement of the anterograde sheath and releasing the proximal end prior to or concurrently with removal of the introducer from the lumen.
  • Where the anchoring means comprises an inflatable balloon, the method comprises inflating the balloon prior to deployment of the anterograde portion of the endoluminal device and deflating the balloon after deployment of the anterograde portion. Where a retrograde sheath is present, the retrograde sheath may be retracted prior to inflating the balloon, such that the balloon is inflated to anchor the proximal end of the endoluminal device against the body lumen. In the alternative, the balloon may be inflated to anchor the proximal end of the endoluminal device against the retrograde sheath, in which case the retrograde sheath is not retracted until after deflating the balloon after the anterograde portion of the endoluminal device has been deployed.
  • Where the anchoring means comprises a tether, the method comprises separating the tether from the endoluminal device prior to or during removal of the introducer from the body. Where the anchoring means comprises an extended portion of the endoluminal device releasably confined in a notch between the retrograde sheath and the medial sheath or between the retrograde sheath and the inner sheath, the method comprises retracting the retrograde sheath sufficient to release the extended portion from the notch after deployment of the anterograde portion of the endoluminal device.
  • For the embodiment wherein the retrograde portion comprises an inflatable balloon mounted inside the retrograde portion, an exemplary method comprises aligning the introducer in a deployment location, retracting at least part of the retrograde portion and deploying the proximal end of the endoluminal device. The balloon is then inflated to compress the endoluminal device against the lumen wall while the shaft is extended to distally advance the anterograde sheath to deploy a remaining portion of the endoluminal device.
  • It is to be understood that both the foregoing general description and the following detailed description are exemplary, but not restrictive, of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention is best understood from the following detailed description when read in connection with the accompanying drawing, in which:
  • FIG. 1A shows a longitudinal section of a standard introducer of the prior art;
  • FIG. 1B shows a detailed longitudinal section of the encircled portion of FIG. 1A;
  • FIG. 2 shows a longitudinal section of an exemplary introducer of the present invention;
  • FIG. 3 shows a flowchart depicting an exemplary method of the invention;
  • FIG. 4A shows a longitudinal section of a portion of an exemplary introducer of the present invention having an extended cell and notch anchoring arrangement and a medial sheath;
  • FIG. 4B shows a longitudinal section of a portion of another exemplary introducer of the present invention having an extended cell and notch anchoring arrangement with no medial sheath;
  • FIG. 5A shows a longitudinal section of a portion of an exemplary introducer of the present invention having a tether attached to the retrograde sheath for anchoring the proximal end of the endoluminal device;
  • FIG. 5B shows a cross section of a portion of another embodiment of an exemplary introducer of the present invention having a channel in the medial sheath for the tether;
  • FIG. 5C shows a longitudinal section of a portion of another exemplary introducer embodiment of the present invention having a tether attached to the inner sheath for anchoring the proximal end of the endoluminal device;
  • FIG. 6 shows a longitudinal section of another exemplary introducer of the present invention having a holder at the distal end of the endoluminal device; and
  • FIG. 7 shows a portion of a longitudinal section of another exemplary introducer of the present invention in which the balloon is contained within the retrograde portion.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The invention will next be illustrated with reference to the figures wherein the same numbers indicate similar elements in all figures. Such figures are intended to be illustrative rather than limiting and are included herewith to facilitate the explanation of the apparatus of the present invention.
  • Referring now to FIG. 2 there is shown an exemplary introducer embodiment of the present invention. Introducer 100 comprises a retrograde portion 102 and an anterograde portion 104. Shaft 106 may be solid or tubular, and is surrounded by three concentrically positioned sheaths: inner sheath 108, medial sheath 110, and retrograde sheath 112. Medial sheath 110 preferably has a fixed position and operates as a radial spacer, separating retrograde sheath distal extension 114 from inner sheath distal extension 116. The distal extension 114 of retrograde sheath 112 and distal extension 116 of inner sheath 108 comprise the respective portions of those sheaths located distally of the distal end 111 of medial sheath 110.
  • Other types of spacers may also be used. For example, radial protrusions on inner sheath or retrograde sheath may provide such spacing. Furthermore, inner sheath may have a stepped outside diameter or retrograde sheath may have a stepped inside diameter, such as created by medial sheath being fused to either inner sheath or retrograde sheath, or by any other method that creates an equivalent structure.
  • Radial space 118 between retrograde sheath 112 and inner sheath 108 may be sufficiently large to allow room for a radial-force-exerting device, such as balloon 120. Inner sheath 108 preferably has a fixed position and may include a lumen for communicating pressurized fluid to balloon 120. Although shown in FIG. 2 with balloon 120 and proximal end 131 of device 130 as part of retrograde portion 102 covered by retrograde sheath 112, in an alternative embodiment shown in FIG. 7, balloon 120 and proximal end 131 of device 130 may be part of anterograde portion 104 and covered by anterograde sheath 126.
  • Anterograde portion 104 of introducer 100 includes a distal extension 122 of shaft 106 and distal extension 116 of inner sheath 108. Distal extension 122 of shaft 106 terminates with an attachment to radial spacer 125 connected to distal tip 124. Distal tip 124 is coupled to anterograde sheath 126, which extends proximally from distal tip 124, and is positioned concentrically about shaft distal extension 122 and inner sheath distal extension 116. Radial spacer 125 creates an area 128 into which an endoluminal device 130, such as a stent graft, can be loaded.
  • Retrograde sheath 112 and anterograde sheath 126 may have a lateral space 132 therebetween, the sheaths may abut one another (not shown) without any space 132, or the sheaths may laterally overlap one another as depicted by dashed lines 140 in FIG. 2. Dashed lines 140 show a proximal extension of anterograde sheath 126 that overlaps retrograde sheath 112. In an alternative embodiment, a similar distal extension (not shown) of retrograde sheath 112 may laterally overlap anterograde sheath 126.
  • An exemplary method for using introducer 100 is depicted in the flowchart shown in FIG. 3. The method may be performed, for example, in an operating room or an angiographic suite, preferably under fluoroscopic guidance as is known in the art. First, the introducer is inserted into a body lumen, as indicated in step 210, distal tip 124 first, from a proximal access site, such as a femoral artery or iliac artery, for vascular deployment. Typically, the introducer is threaded into the lumen over a guidewire (not shown) as is well known in the art. The access site may be surgically exposed and punctured with, for example, an 18-gauge needle as is known in the art.
  • Next, in step 220, the proximal end 131 of endoluminal device 130 is aligned in an appropriate deployment position. Fluoroscopic guidance and/or a guide wire may be used to guide proximal end 131 into the desired position. For example, where endoluminal device 130 is an AAA stent graft, proximal end 131 of device 130 is positioned in the iliac (not shown), preferably just above a branch of the internal iliac artery (not shown).
  • Then, in step 230, retrograde sheath 112 is retracted at least far enough to expose proximal end 131 of device 130 and balloon 120. In an alternative embodiment wherein the proximal end 131 and balloon 120 are located under anterograde sheath 126, the anterograde sheath 126 is initially advanced far enough to expose the proximal end and balloon. Balloon 120 is inflated in step 240, such as by pressurizing balloon 120 with fluid communicated via a lumen in inner sheath 108, to exert radial force that compresses the retrograde portion 133 of device 130 against the lumen wall (not shown). Although the various lumens are shown concentrically, other configurations, including side-by-side lumen can be used. Such other configurations are described in an application titled “APPARATUS AND METHOD FOR DEPLOYMENT OF AN ENDOLUMINAL DEVICE,” by Johnson et al., Ratner & Prestia docket number BSI-498US, filed the same day as this application and assigned to the common assignee of this application, incorporated herein by reference. In step 250, shaft 106 is extended distally to deploy the anterograde portion 135 of device 130. Prior to extending the shaft, the guidewire and retrograde sheath 112 may typically be locked together to prevent movement of the retrograde sheath or the guidewire during extension of the shaft. As used herein, the “retrograde portion” of device 130 refers to any portion initially covered by the retrograde sheath (as shown in FIG. 2) or any portion underlied by balloon 120 and any portion proximal thereof (as shown in FIG. 7), and the “anterograde portion” refers to the remainder of the device distal of the retrograde portion. Balloon 120 is then deflated in step 260 and introducer 100 is removed from the lumen in accordance with step 270. If desired, prior to removal from the lumen, balloon 120 may be used for modeling device 130 to better conform to the contours of the lumen wall, as is known in the art. Thus, introducer 100 and the method depicted in FIG. 3 provides means for accurately placing the proximal end of an endoluminal device.
  • In an alternative method, step 240 of inflating balloon 120 may be carried out prior to step 230 of retracting retrograde sheath 112, so that the balloon exerts radial force compressing retrograde portion 133 of device 130 into the retrograde sheath. Then, after step 250 of extending shaft 106 to deploy anterograde portion 135 of device 130, balloon 120 is deflated in step 260 and retrograde sheath 106 is retracted in step 230 to complete deployment of the retrograde portion of the device. Finally, the introducer is removed in step 270. Thus, in a first method, the steps are performed in numerical order as shown in FIG. 3, and in a second method, the steps are performed in the step order 210-220-240-250-260-230-270. The second method has the advantage that the balloon does not press against the lumen wall, but instead presses against the retrograde sheath, thus avoiding exertion of stress on the lumen wall. This second method is particularly desirable in the case of diseased lumen walls, which could be damaged due to the force of the balloon. This method, however, may sacrifice a few millimeters of accuracy due to recoil of the device 130. Consequently, the second method may be more desirable for applications in which the small sacrifice in accuracy is medically acceptable.
  • As an alternative to balloon 120, other means for holding proximal end 131 of device 130 may be employed. For example, as shown in FIG. 4A, a notch 150 may be located in medial sheath 110 a. A proximally extended portion 131 a of device 130 a, such as an extended cell or a loop, is fixed within notch 150. In the method shown in FIG. 3, the retrograde sheath 112 is only retracted in step 230 until the proximal end 131 of stent 130 deploys, except for proximally extended portion 131 a. A radiopaque deployment marker (not shown) may be used to mark the end 131 so that the retrograde sheath is not retracted too far. Steps 240 and 260 are omitted from the method steps, as proximally extended portion 131 a remains compressed in notch 150 between medial sheath 110 a and retrograde sheath 112 to hold the proximal end 131 of device 130 in place until the distal portion of the stent has been deployed. Then, prior to removing deployment device in step 270, retrograde sheath 112 is retracted the remaining distance necessary to release proximally extended portion 131 a from notch 150.
  • In yet another alternate embodiment, shown in FIG. 5A, a tether 152 may be used for anchoring. Distal end 153 of tether 152 is attached to proximal end 131 of device 130 and proximal end 154 of the tether may be attached to the distal end of either retrograde sheath 112 (as shown in FIG. 5A) or medial sheath 110 (not shown), or to an intermediate portion of inner sheath 108 (shown in FIG. 5C). Tether 152 may be attached to device 130 and sheath 112 or 110 in any way known in the art, such as by gluing, suturing, stapling, welding, heat shrinking, and the like. The tether may comprise any type of material known in the art, including metal or non-metal filaments. Preferably, the tether is attached to the device in such a way that it is readily detachable from the device when desired. Suitable mechanism for detachably connecting a wire to an implantable device are described in U.S. Pat. No. 5,354,295 and U.S. Pat. No. 5,122,136 to Guglielmi et al., as well as in U.S. patent application Ser. No. 09/852,524, filed on May 10, 2001, by Chris Elliott on behalf of the assignee of this invention, all of which are incorporated herein by reference.
  • Although shown in FIG. 5A attached to the distal end of retrograde sheath 112, tether 152 may be employed in any way known in the art, including extending proximally all the way back to the access location outside the body lumen. For example, as shown in the cross-sectional illustration of FIG. 5B, medial sheath 110 a may have a lateral channel running its entire length into which tether 152 may extend. Thus, tether 152 may connect to a power supply or a handle for exerting tensional or torsional force, as described in the '524 application.
  • For tethered embodiments, the method is carried out as shown in FIG. 3 up to step 230, at which point the retrograde sheath 112 is retracted until proximal end 131 of the device 130 deploys, with tether 152 holding proximal end 131 in place. The guidewire is then typically locked with retrograde sheath 112 to prevent further movement of the retrograde sheath 112, and anterograde sheath 126 is advanced by advancing shaft 106 to deploy the anterograde portion of device 130. Then, the remainder of retrograde sheath 112 is retracted as part of step 270 to release device 130 from tether 152. If proximal end 154 of tether 152 is attached to medial sheath 110 instead of retrograde sheath 112, the medial sheath may be retracted, or if the medial sheath is not retractable, the entire introducer may be retracted to release device 130 from tether 152 in step 270.
  • Another introducer embodiment 600 is shown in FIG. 6. In this embodiment, all of the components are essentially the same as in embodiment 100, except that instead of a combination of balloon 120 and retrograde sheath 112 at the proximal end, there is a holder 602 near the distal end of inner sheath extension 116. Anterograde sheath 126 (and thus anterograde portion 104 of introducer 600) extends to the proximal end 131 of device 130. Holder 602 may comprise any material known in the art and may have any geometry known in the art sufficient to hold device 130 in place while anterograde sheath is advanced. A number of geometries and materials useful for holding a stent in place from inside the stent are described in U.S. application Ser. No. 09/574,418 by Sullivan et al., filed on May 19, 2000, assigned to the assignee of this invention, and incorporated herein by reference. For example, holder 602 may be a sleeve of a relatively higher friction material than sheath 126 such that device 130 is frictionally retained while sheath 126 advances. In another embodiment, holder 602 may comprise one or more radial protrusions that exerts an axial restraining force against individual members of device 130. Other structures or combinations of multiple structures may also be used as holders.
  • A holder 602 at or near the distal end of device 130 as shown in FIG. 6 may be beneficial for combination with a balloon at or near the proximal end of the device as shown in FIG. 7. Such a holder 602 may minimize potential distal advancement of proximal end 131 of device 130 during the initial advancement of sheath 126 to expose balloon 120, as may otherwise potentially occur as a result of frictional contact between the anterograde sheath and the device. In the embodiment shown in FIG. 7, balloon 120 may also be provided with a greater frictional engagement force than sheath 126 so that device 130 tends to stay with the balloon rather than move with the sheath. Such a greater frictional engagement force may be the result of a higher coefficient of friction, for example.
  • Thus, the method of using introducer 600, referring back to FIG. 3, involves steps 210, 220, 250, and 270, without any of the steps relating to the balloon or the retrograde shaft. In fact, the embodiment shown in FIG. 6 may comprise a minimal set of components comprising shaft 106, inner sheath 108, holder 602 mounted directly to the inner sheath 108, and tip 124 attached to anterograde sheath 126. The remaining components shown in FIG. 6 are optional.
  • Holder 602 is not limited to restraining only the distal end of device 130. For example, holder 602 may extend the length of device 130, an embodiment that may be particularly useful with devices having a relatively low column strength. A hybrid of introducers 100 and 600 may also be provided comprising both a holder 602 and a balloon 120 or other anchoring means at proximal end 131 of device 130, with anterograde sheath 126 extending over the proximal end of the device. In such a configuration comprising a balloon, the deployment method follows the method steps in the order shown in FIG. 3, except that in step 230 instead of retracting retrograde sheath 112, the method comprises advancing anterograde sheath a sufficient distance to uncover balloon 120, and then inflating the balloon at step 240 and continuing on with the remainder of the method steps. As balloon 120, once inflated, is capable of anchoring device 130, holder 602 may be located closer to proximal end 131 of the device so that it engages the device only during the initial advancement of anterograde sheath 126 prior to inflation of the balloon.
  • Tethered or extended-portion-and-notch embodiments may also be provided with anterograde sheath 126 extending to the proximal end of endoluminal device 130. In an extended-portion-and-notch embodiment shown in FIG. 4B, there may be no medial sheath, such that retrograde sheath 112 a directly contacts inner sheath 108 a, and the notch 150 may be in inner sheath 108 a, retrograde sheath 112 a, or may comprise notch portions 150 a and 150 b in each, respectively, as shown in FIG. 4B. The medial sheath may optionally be present, such as to preserve a constant radial profile throughout the introducer, in which case the notch or a portion of the notch may be located in one or both of the retrograde sheath and the medial sheath. The method of using such an embodiment comprises inserting the device in step 210, aligning the proximal end in step 220, extending the shaft to deploy the device 250, and then retracting the retrograde sheath in step 230 a sufficient distance to release the extended portion from the notch.
  • In a tethered embodiment with anterograde sheath 126 extending to the proximal end of endoluminal device 130, as shown in FIG. 5C there may be no medial sheath or retrograde sheath, and tether 152 may just be attached to an intermediate portion of inner sheath 108 as shown in FIG. 5C, or may extend freely (not shown) through the lumen back through the access location and outside the lumen to some means for manipulating the tether, such as the means shown and described in '524 application. As shown in FIG. 5C, tether 152 is wrapped about inner sheath 108 in a manner than fixes it axially and may be further anchored in place with an adhesive. Notch 155 in tether provides a predetermined weak spot so that the retraction of the introducer is sufficient to break the tether at the notch. It is important that the amount of force required to break tether 152 at a preferred location, such as notch 155, is less than the amount of force that will break the tether in other locations or remove the affixation of the tether to inner sheath, more than the amount of force necessary to hold proximal end 131 of endoluminal device 130 in place during deployment of its distal end (so that it does not break prematurely), and less than the amount of force that will axially move device 130 once deployed in the lumen (so that breaking the tether does not take the deployed device out of its proper alignment). The tether may also be affixed in a slipknot that requires an amount of force to undo the knot that does not break the tether, pull the deployed device out of alignment, or undo prematurely.
  • One concern of the reverse deployment method and introducers described herein is that if the anterograde portion is too long, it may enter the heart during deployment of an AAA stent graft. Other, non-AAA applications may have similar concerns with surrounding organs or other body structure. Thus, the dimensions of the introducer may be optimized to prevent damage caused by the anterograde portion being too long. One way of shortening the anterograde portion for a particular application is to lengthen the retrograde portion. Thus, although shown in FIGS. 2 and 6 with anterograde portion extending over the majority of the length of device 130, in other embodiments the anterograde portion and retrograde portions may extend over equal lengths of the device, or portion of the device over which the retrograde portion extends may be longer than the portion over which the anterograde portion extends. Such embodiments, for example an introducer wherein the retrograde and anterograde portions extend over equal lengths of the device, may be useful where the location of the proximal end of the device is less important than aligning the middle of the device with a certain region of a lumen.
  • Although illustrated and described herein with reference to certain specific embodiments, the present invention is nevertheless not intended to be limited to the details shown. Rather, various modifications may be made in the details within the scope and range of equivalents of the claims and without departing from the spirit of the invention.

Claims (20)

1. A method for deployment of an endoluminal device in a distal location in a body lumen from a proximal location, the method comprising the steps of:
inserting an introducer into the body lumen, the introducer comprising a retrograde portion; an anterograde portion; a shaft having a distal tip; an inner sheath mounted concentrically over the shaft with the endoluminal device mounted concentrically over the inner sheath; and an anterograde sheath proximally attached to the shaft distal tip, mounted over the endoluminal device in the anterograde portion of the introducer, and axially moveable relative to the inner sheath;
aligning the introducer in a deployment location;
extending the shaft to distally advance the anterograde sheath to deploy at least a proximal portion of the endoluminal device; and
removing the introducer from the body lumen.
2. The method of claim 1, wherein the introducer further comprises anchoring means in the anterograde portion for anchoring the endoluminal device during deployment of the device from a proximal end to a distal end of the device, the method comprising aligning the proximal end of the device with the deployment location and confining the endoluminal device between the anchoring means and the advancing anterograde sheath.
3. The method of claim 1, wherein the introducer further comprises anchoring means in the retrograde portion for anchoring the endoluminal device during deployment of the device from a proximal end to a distal end of the device, the method comprising aligning the proximal end of the device with the deployment location, anchoring the proximal end, and releasing proximal end prior to or concurrently with removing the introducer from the body lumen.
4. The method of claim 3, wherein the anchoring means comprises an inflatable balloon, and the method further comprises inflating the balloon prior to extending the shaft to distally advance the anterograde sheath and deflating the balloon after extending the shaft to distally advance the anterograde sheath.
5. The method of claim 4, further comprising a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath and extending axially over the proximal end of the endoluminal device and the balloon, the method further comprising retracting the retrograde sheath prior to inflating the balloon, and inflating the balloon to anchor the proximal end of the endoluminal device against the body lumen.
6. The method of claim 4, further comprising a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath and extending axially over the proximal end of the endoluminal device and the balloon, the method further comprising inflating the balloon to anchor the proximal end of the endoluminal device against the retrograde sheath and then retracting the retrograde sheath after deflating the balloon.
7. The method of claim 3, wherein the anchoring means comprises a tether releasably attached to the proximal end of the endoluminal device, the method comprising separating the tether from the endoluminal device prior to removing the introducer from the body lumen.
8. The method of claim 7, wherein the introducer further comprises a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath; a medial sheath mounted concentrically between the inner sheath and the retrograde sheath in the retrograde portion of the introducer and terminating proximally of the proximal end of the endoluminal device; and the anchoring means comprises a tether releasably attached to the proximal end of the endoluminal device and non-releasably attached to a distal end of the retrograde sheath, the method comprising retracting the retrograde sheath to separate the tether from the endoluminal device prior to removing the introducer from the body lumen.
9. The method of claim 8, wherein a portion of the retrograde sheath extends over a portion of the endoluminal device, the method comprising retracting the portion of the retrograde sheath extending over the endoluminal device prior to extending the shaft to distally advance the anterograde sheath.
10. The method of claim 7, wherein the introducer further comprises a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath and the anchoring means comprises a tether releasably attached to the proximal end of the endoluminal device and non-releasably attached the inner sheath, the method comprising separating the tether from the endoluminal device while removing the introducer from the body lumen.
11. The method of claim 3, wherein the introducer further comprises a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath; a medial sheath mounted concentrically between the inner sheath and the retrograde sheath in the retrograde portion of the introducer and terminating proximally of the proximal end of the endoluminal device; and the anchoring means comprises a proximally extended portion of the endoluminal device and a notch in one or both of the medial sheath and the retrograde sheath, the method further comprising releasably confining the extended portion between the retrograde sheath and the medial sheath until after extending the shaft to distally advance the anterograde sheath, and then retracting the retrograde sheath relative to the medial sheath a distance sufficient to release the extended portion from the notch.
12. The method of claim 11, wherein the retrograde sheath extends over a retrograde portion of the endoluminal device, the method comprising retracting the portion of the retrograde sheath extending over the endoluminal device prior to extending the shaft to distally advance the anterograde sheath.
13. The method of claim 3, wherein the introducer further comprises a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath and the anchoring means comprises a proximally extended portion of the endoluminal device and a notch in one or both of the inner sheath and the retrograde sheath, the method further comprising releasably confining the extended portion between the retrograde sheath and the inner sheath until after extending the shaft to distally advance the anterograde sheath, and then retracting the retrograde sheath relative to the inner sheath sufficient to release the extended portion from the notch.
14. A method for deployment of an endoluminal device in a distal location in a body lumen from a proximal location, the method comprising the steps of:
inserting an introducer into the body lumen having a lumen wall, the introducer comprising a retrograde portion, an anterograde portion comprising a distal tip and an anterograde sheath attached proximally to the distal tip, a shaft attached to the distal tip and extending concentrically through a central lumen defined by the anterograde portion and retrograde portion, an endoluminal device mounted concentrically over the shaft in the central lumen and having a distal end contained by the anterograde portion and a proximal end contained by the retrograde portion, an inflatable balloon mounted inside the retrograde portion for anchoring the endoluminal device during deployment of the device, and a proximally retractable retrograde sheath extending distally over the balloon and the proximal end of the endoluminal device;
aligning the proximal end of the endoluminal device in a deployment location;
inflating the balloon to anchor the proximal end of the endoluminal device; and
extending the shaft to distally advance the anterograde sheath to deploy a portion of the endoluminal device.
15. The method of claim 14, further comprising a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath and extending axially over the proximal end of the endoluminal device and the balloon, the method further comprising retracting the retrograde sheath prior to inflating the balloon, and inflating the balloon to anchor the proximal end of the endoluminal device against the body lumen.
16. The method of claim 14, further comprising a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath and extending axially over the proximal end of the endoluminal device and the balloon, the method further comprising inflating the balloon to anchor the proximal end of the endoluminal device against the retrograde sheath and then retracting the retrograde sheath after deflating the balloon.
17. A method for deployment of an endoluminal device in a distal location in a body lumen from a proximal location, the method comprising the steps of:
inserting an introducer into the body lumen, the introducer comprising a retrograde portion; an anterograde portion; a shaft having a distal tip; an inner sheath mounted concentrically over the shaft with the endoluminal device mounted concentrically over the inner sheath; and an anterograde sheath proximally attached to the shaft distal tip, mounted over the endoluminal device in the anterograde portion of the introducer, and axially moveable relative to the inner sheath; and a tether releasably attached to the proximal end of the endoluminal device for anchoring the endoluminal device during deployment of the device;
aligning the proximal end of the device with the deployment location;
anchoring the proximal end of the endoluminal device with the tether;
extending the shaft to distally advance the anterograde sheath to deploy at least a proximal portion of the endoluminal device; and
removing the introducer from the body lumen.
18. The method of claim 17, wherein the introducer further comprises a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath; a medial sheath mounted concentrically between the inner sheath and the retrograde sheath in the retrograde portion of the introducer and terminating proximally of the proximal end of the endoluminal device; and the tether releasably attached to the proximal end of the endoluminal device and non-releasably attached to a distal end of the retrograde sheath, the method comprising retracting the retrograde sheath to separate the tether from the endoluminal device prior to removing the introducer from the body lumen.
19. The method of claim 18, wherein a portion of the retrograde sheath extends over a portion of the endoluminal device, the method comprising retracting the portion of the retrograde sheath extending over the endoluminal device prior to extending the shaft to distally advance the anterograde sheath.
20. The method of claim 17, wherein the introducer further comprises a proximally retractable retrograde sheath mounted concentrically over the shaft and inner sheath and the tether releasably attached to the proximal end of the endoluminal device and non-releasably attached the inner sheath, the method comprising separating the tether from the endoluminal device while removing the introducer from the body lumen.
US12/987,083 2002-02-22 2011-01-08 Method and apparatus for deployment of an endoluminal device Abandoned US20110106235A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/987,083 US20110106235A1 (en) 2002-02-22 2011-01-08 Method and apparatus for deployment of an endoluminal device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/081,641 US7887573B2 (en) 2002-02-22 2002-02-22 Method and apparatus for deployment of an endoluminal device
US11/363,015 US7892272B2 (en) 2002-02-22 2006-02-27 Method and apparatus for deployment of an endoluminal device
US12/987,083 US20110106235A1 (en) 2002-02-22 2011-01-08 Method and apparatus for deployment of an endoluminal device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/363,015 Continuation US7892272B2 (en) 2002-02-22 2006-02-27 Method and apparatus for deployment of an endoluminal device

Publications (1)

Publication Number Publication Date
US20110106235A1 true US20110106235A1 (en) 2011-05-05

Family

ID=27752977

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/081,641 Expired - Fee Related US7887573B2 (en) 2002-02-22 2002-02-22 Method and apparatus for deployment of an endoluminal device
US11/363,015 Expired - Fee Related US7892272B2 (en) 2002-02-22 2006-02-27 Method and apparatus for deployment of an endoluminal device
US12/987,083 Abandoned US20110106235A1 (en) 2002-02-22 2011-01-08 Method and apparatus for deployment of an endoluminal device

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/081,641 Expired - Fee Related US7887573B2 (en) 2002-02-22 2002-02-22 Method and apparatus for deployment of an endoluminal device
US11/363,015 Expired - Fee Related US7892272B2 (en) 2002-02-22 2006-02-27 Method and apparatus for deployment of an endoluminal device

Country Status (9)

Country Link
US (3) US7887573B2 (en)
EP (1) EP1482866B1 (en)
JP (1) JP4364647B2 (en)
AT (1) ATE357196T1 (en)
AU (1) AU2003215288A1 (en)
CA (1) CA2476734C (en)
DE (1) DE60312662T2 (en)
ES (1) ES2283757T3 (en)
WO (1) WO2003071988A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8579958B2 (en) 2002-03-12 2013-11-12 Covidien Lp Everting stent and stent delivery system
US8591566B2 (en) 2012-02-23 2013-11-26 Covidien Lp Methods and apparatus for luminal stenting
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
US9078659B2 (en) 2012-04-23 2015-07-14 Covidien Lp Delivery system with hooks for resheathability
WO2015196157A3 (en) * 2014-06-19 2016-02-11 Endosphere, Inc. Duodenal gastrointestinal devices and delivery mechanisms
US9474639B2 (en) 2013-08-27 2016-10-25 Covidien Lp Delivery of medical devices
US9724222B2 (en) 2012-07-20 2017-08-08 Covidien Lp Resheathable stent delivery system
US9782186B2 (en) 2013-08-27 2017-10-10 Covidien Lp Vascular intervention system
US10130500B2 (en) 2013-07-25 2018-11-20 Covidien Lp Methods and apparatus for luminal stenting
US10376396B2 (en) 2017-01-19 2019-08-13 Covidien Lp Coupling units for medical device delivery systems
US10786377B2 (en) 2018-04-12 2020-09-29 Covidien Lp Medical device delivery
US11071637B2 (en) 2018-04-12 2021-07-27 Covidien Lp Medical device delivery
US11123209B2 (en) 2018-04-12 2021-09-21 Covidien Lp Medical device delivery
US11413174B2 (en) 2019-06-26 2022-08-16 Covidien Lp Core assembly for medical device delivery systems
US11413176B2 (en) 2018-04-12 2022-08-16 Covidien Lp Medical device delivery

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US6733525B2 (en) 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
US6893460B2 (en) 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7887573B2 (en) * 2002-02-22 2011-02-15 Boston Scientific Scimed, Inc. Method and apparatus for deployment of an endoluminal device
US7004964B2 (en) * 2002-02-22 2006-02-28 Scimed Life Systems, Inc. Apparatus and method for deployment of an endoluminal device
US7553324B2 (en) * 2003-10-14 2009-06-30 Xtent, Inc. Fixed stent delivery devices and methods
US7326236B2 (en) 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US7323006B2 (en) 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US20050246008A1 (en) * 2004-04-30 2005-11-03 Novostent Corporation Delivery system for vascular prostheses and methods of use
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US8628564B2 (en) 2004-05-25 2014-01-14 Covidien Lp Methods and apparatus for luminal stenting
AU2010236494B2 (en) 2004-05-25 2013-05-30 Covidien Lp Vascular stenting for aneurysms
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
EP1750619B1 (en) 2004-05-25 2013-07-24 Covidien LP Flexible vascular occluding device
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20050288766A1 (en) 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
EP1883371B1 (en) 2005-05-25 2015-10-07 Covidien LP System and method for delivering and deploying and occluding device within a vessel
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US7670365B2 (en) * 2005-09-23 2010-03-02 BostonScientific Scimed, Inc. Secured stent delivery system
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
US8652198B2 (en) 2006-03-20 2014-02-18 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US20080114437A1 (en) * 2006-11-13 2008-05-15 Boston Scientific Scimed, Inc. Self-expanding side branch bifurcated stent
JP5593545B2 (en) 2006-12-06 2014-09-24 メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. System and method for transapical delivery of a self-expanding valve secured to an annulus
US8236045B2 (en) 2006-12-22 2012-08-07 Edwards Lifesciences Corporation Implantable prosthetic valve assembly and method of making the same
US20080199510A1 (en) * 2007-02-20 2008-08-21 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8486132B2 (en) * 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
KR100822045B1 (en) * 2007-04-23 2008-04-15 (주) 태웅메디칼 Proximal release type stent delivery device
WO2009062264A1 (en) * 2007-11-15 2009-05-22 Endogad Research Pty Limited Hybrid intraluminal device
WO2009091509A1 (en) * 2008-01-16 2009-07-23 St. Jude Medical, Inc. Delivery and retrieval systems for collapsible/expandable prosthetic heart valves
EP2594230B1 (en) 2008-02-29 2021-04-28 Edwards Lifesciences Corporation Expandable member for deploying a prosthetic device
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US8323335B2 (en) 2008-06-20 2012-12-04 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves and methods for using
US8652202B2 (en) 2008-08-22 2014-02-18 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US8690936B2 (en) 2008-10-10 2014-04-08 Edwards Lifesciences Corporation Expandable sheath for introducing an endovascular delivery device into a body
US8986361B2 (en) * 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
GB0901496D0 (en) * 2009-01-29 2009-03-11 Angiomed Ag Delivery device for delivering a stent device
EP2475336A1 (en) * 2009-09-10 2012-07-18 NovoStent Corporation Vascular prosthesis assembly with retention mechanism and method
US8449599B2 (en) 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
WO2011081997A1 (en) * 2009-12-30 2011-07-07 Wilson-Cook Medical Inc. Proximal release delivery device
US8864811B2 (en) * 2010-06-08 2014-10-21 Veniti, Inc. Bi-directional stent delivery system
US9155619B2 (en) 2011-02-25 2015-10-13 Edwards Lifesciences Corporation Prosthetic heart valve delivery apparatus
US20120266892A1 (en) * 2011-04-21 2012-10-25 Hologic, Inc. Tethered implant and related method of use
US9289282B2 (en) 2011-05-31 2016-03-22 Edwards Lifesciences Corporation System and method for treating valve insufficiency or vessel dilatation
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US20140067048A1 (en) 2012-09-06 2014-03-06 Edwards Lifesciences Corporation Heart Valve Sealing Devices
US9114001B2 (en) 2012-10-30 2015-08-25 Covidien Lp Systems for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US20140142688A1 (en) * 2012-11-20 2014-05-22 Medtronic CV Luxembourg S.a.r.l. Medical Device Delivery System and Methods of Delivering a Medical Device
US9439763B2 (en) 2013-02-04 2016-09-13 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US9168129B2 (en) 2013-02-12 2015-10-27 Edwards Lifesciences Corporation Artificial heart valve with scalloped frame design
JP6515088B2 (en) 2013-05-20 2019-05-15 エドワーズ ライフサイエンシーズ コーポレイションEdwards Lifesciences Corporation Prosthetic heart valve delivery device
US9622863B2 (en) 2013-11-22 2017-04-18 Edwards Lifesciences Corporation Aortic insufficiency repair device and method
US10098734B2 (en) 2013-12-05 2018-10-16 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US9532870B2 (en) 2014-06-06 2017-01-03 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
US10195026B2 (en) 2014-07-22 2019-02-05 Edwards Lifesciences Corporation Mitral valve anchoring
US10058424B2 (en) 2014-08-21 2018-08-28 Edwards Lifesciences Corporation Dual-flange prosthetic valve frame
KR101696811B1 (en) * 2015-02-10 2017-01-17 주식회사 엠아이텍 Catheter
US10064718B2 (en) 2015-04-16 2018-09-04 Edwards Lifesciences Corporation Low-profile prosthetic heart valve for replacing a mitral valve
US10010417B2 (en) 2015-04-16 2018-07-03 Edwards Lifesciences Corporation Low-profile prosthetic heart valve for replacing a mitral valve
US10376364B2 (en) 2015-11-10 2019-08-13 Edwards Lifesciences Corporation Implant delivery capsule
US10470876B2 (en) 2015-11-10 2019-11-12 Edwards Lifesciences Corporation Transcatheter heart valve for replacing natural mitral valve
US20170290691A1 (en) * 2016-04-12 2017-10-12 Idev Technologies, Inc. Stent deployment system including multiple stent-engaging elements
US10687969B2 (en) 2016-06-29 2020-06-23 Boston Scientific Scimed, Inc. Stent delivery system
US10857016B2 (en) 2017-04-26 2020-12-08 Boston Scientific Scimed, Inc. Proximal and distal release delivery system
US10959846B2 (en) 2017-05-10 2021-03-30 Edwards Lifesciences Corporation Mitral valve spacer device

Citations (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4787899A (en) * 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US4950227A (en) * 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US5078720A (en) * 1990-05-02 1992-01-07 American Medical Systems, Inc. Stent placement instrument and method
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5148548A (en) * 1989-12-19 1992-09-15 Northern Telecom Limited Method of monitoring cellular radio channels to avoid adjacent and co-channel interference
US5158548A (en) * 1990-04-25 1992-10-27 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5201757A (en) * 1992-04-03 1993-04-13 Schneider (Usa) Inc. Medial region deployment of radially self-expanding stents
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5409495A (en) * 1993-08-24 1995-04-25 Advanced Cardiovascular Systems, Inc. Apparatus for uniformly implanting a stent
US5415664A (en) * 1994-03-30 1995-05-16 Corvita Corporation Method and apparatus for introducing a stent or a stent-graft
US5445646A (en) * 1993-10-22 1995-08-29 Scimed Lifesystems, Inc. Single layer hydraulic sheath stent delivery apparatus and method
US5456694A (en) * 1994-05-13 1995-10-10 Stentco, Inc. Device for delivering and deploying intraluminal devices
US5480423A (en) * 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US5591228A (en) * 1995-05-09 1997-01-07 Edoga; John K. Methods for treating abdominal aortic aneurysms
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5634928A (en) * 1994-12-07 1997-06-03 Fischell Robert Integrated dual-function catheter system and method for balloon angioplasty and stent delivery
US5662675A (en) * 1995-02-24 1997-09-02 Intervascular, Inc. Delivery catheter assembly
US5683451A (en) * 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5695499A (en) * 1994-10-27 1997-12-09 Schneider (Usa) Inc. Medical device supported by spirally wound wire
US5800526A (en) * 1995-03-17 1998-09-01 Endotex Interventional Systems, Inc. Multi-anchor stent
US5800519A (en) * 1994-04-29 1998-09-01 Kopin Corporation Tubular medical prosthesis for use in a body lumen
US5807101A (en) * 1996-01-17 1998-09-15 Scalzo; Josephine Universal occlusal matrix
US5817101A (en) * 1997-03-13 1998-10-06 Schneider (Usa) Inc Fluid actuated stent delivery system
US5824041A (en) * 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
US5843164A (en) * 1994-11-15 1998-12-01 Advanced Carrdiovascular Systems, Inc. Intraluminal stent for attaching a graft
US5860998A (en) * 1996-11-25 1999-01-19 C. R. Bard, Inc. Deployment device for tubular expandable prosthesis
US5873907A (en) * 1998-01-27 1999-02-23 Endotex Interventional Systems, Inc. Electrolytic stent delivery system and methods of use
US5989280A (en) * 1993-10-22 1999-11-23 Scimed Lifesystems, Inc Stent delivery apparatus and method
US6022336A (en) * 1996-05-20 2000-02-08 Percusurge, Inc. Catheter system for emboli containment
US6042589A (en) * 1998-03-17 2000-03-28 Medicorp, S.A. Reversible-action endoprosthesis delivery device
US6068634A (en) * 1996-08-23 2000-05-30 Scimed Life Systems, Inc. Stent delivery system
US6102942A (en) * 1998-03-30 2000-08-15 Endovascular Technologies, Inc. Stent/graft deployment catheter with a stent/graft attachment mechanism
US6168610B1 (en) * 1994-02-10 2001-01-02 Endovascular Systems, Inc. Method for endoluminally excluding an aortic aneurysm
US6183443B1 (en) * 1992-10-15 2001-02-06 Scimed Life Systems, Inc. Expandable introducer sheath
US6203558B1 (en) * 1996-08-23 2001-03-20 Scimed Life Systems, Inc. Stent delivery system having stent securement apparatus
US6290710B1 (en) * 1999-12-29 2001-09-18 Advanced Cardiovascular Systems, Inc. Embolic protection device
US20010044648A1 (en) * 1998-02-05 2001-11-22 Medtronic, Inc. Radially-expandable stent and delivery system
US6322586B1 (en) * 2000-01-10 2001-11-27 Scimed Life Systems, Inc. Catheter tip designs and method of manufacture
US6468244B1 (en) * 1997-12-19 2002-10-22 James E. Leone Catheter system having fullerenes and method
US20030050684A1 (en) * 2001-09-10 2003-03-13 Abrams Robert M. Internal restraint for delivery of self-expanding stents
US6544223B1 (en) * 2001-01-05 2003-04-08 Advanced Cardiovascular Systems, Inc. Balloon catheter for delivering therapeutic agents
US6582460B1 (en) * 2000-11-20 2003-06-24 Advanced Cardiovascular Systems, Inc. System and method for accurately deploying a stent
US6585758B1 (en) * 1999-11-16 2003-07-01 Scimed Life Systems, Inc. Multi-section filamentary endoluminal stent
US6607551B1 (en) * 1999-05-20 2003-08-19 Scimed Life Systems, Inc. Stent delivery system with nested stabilizer
US6610087B1 (en) * 1999-11-16 2003-08-26 Scimed Life Systems, Inc. Endoluminal stent having a matched stiffness region and/or a stiffness gradient and methods for providing stent kink resistance
US20030163155A1 (en) * 2002-02-22 2003-08-28 Haverkost Patrick A. Method and apparatus for deployment of an endoluminal device
US6613075B1 (en) * 1999-10-27 2003-09-02 Cordis Corporation Rapid exchange self-expanding stent delivery catheter system
US6716238B2 (en) * 2001-05-10 2004-04-06 Scimed Life Systems, Inc. Stent with detachable tethers and method of using same
US7004964B2 (en) * 2002-02-22 2006-02-28 Scimed Life Systems, Inc. Apparatus and method for deployment of an endoluminal device
US7235095B2 (en) * 2002-02-22 2007-06-26 Scimed Life Systems, Inc. Method and system for deploying multi-part endoluminal devices

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628783A (en) 1991-04-11 1997-05-13 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
US5693084A (en) 1991-10-25 1997-12-02 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
CA2125258C (en) 1993-08-05 1998-12-22 Dinah B Quiachon Multicapsule intraluminal grafting system and method
DK176341B1 (en) 1996-09-06 2007-08-27 Cook William Europ Aggregate for transluminal insertion of a tubular stent and an endovascular graft device
AUPO700897A0 (en) 1997-05-26 1997-06-19 William A Cook Australia Pty Ltd A method and means of deploying a graft
US6520983B1 (en) 1998-03-31 2003-02-18 Scimed Life Systems, Inc. Stent delivery system
DE19936980C1 (en) 1999-08-05 2001-04-26 Aesculap Ag & Co Kg Insertion catheter for vascular prostheses

Patent Citations (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4787899A (en) * 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4950227A (en) * 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US5148548A (en) * 1989-12-19 1992-09-15 Northern Telecom Limited Method of monitoring cellular radio channels to avoid adjacent and co-channel interference
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5158548A (en) * 1990-04-25 1992-10-27 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5078720A (en) * 1990-05-02 1992-01-07 American Medical Systems, Inc. Stent placement instrument and method
US5201757A (en) * 1992-04-03 1993-04-13 Schneider (Usa) Inc. Medial region deployment of radially self-expanding stents
US6183443B1 (en) * 1992-10-15 2001-02-06 Scimed Life Systems, Inc. Expandable introducer sheath
US5480423A (en) * 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US5409495A (en) * 1993-08-24 1995-04-25 Advanced Cardiovascular Systems, Inc. Apparatus for uniformly implanting a stent
US5445646A (en) * 1993-10-22 1995-08-29 Scimed Lifesystems, Inc. Single layer hydraulic sheath stent delivery apparatus and method
US5989280A (en) * 1993-10-22 1999-11-23 Scimed Lifesystems, Inc Stent delivery apparatus and method
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US6168610B1 (en) * 1994-02-10 2001-01-02 Endovascular Systems, Inc. Method for endoluminally excluding an aortic aneurysm
US5415664A (en) * 1994-03-30 1995-05-16 Corvita Corporation Method and apparatus for introducing a stent or a stent-graft
US5800519A (en) * 1994-04-29 1998-09-01 Kopin Corporation Tubular medical prosthesis for use in a body lumen
US5456694A (en) * 1994-05-13 1995-10-10 Stentco, Inc. Device for delivering and deploying intraluminal devices
US5824041A (en) * 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
US5683451A (en) * 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5695499A (en) * 1994-10-27 1997-12-09 Schneider (Usa) Inc. Medical device supported by spirally wound wire
US5843164A (en) * 1994-11-15 1998-12-01 Advanced Carrdiovascular Systems, Inc. Intraluminal stent for attaching a graft
US5634928A (en) * 1994-12-07 1997-06-03 Fischell Robert Integrated dual-function catheter system and method for balloon angioplasty and stent delivery
US5662675A (en) * 1995-02-24 1997-09-02 Intervascular, Inc. Delivery catheter assembly
US5800526A (en) * 1995-03-17 1998-09-01 Endotex Interventional Systems, Inc. Multi-anchor stent
US5591228A (en) * 1995-05-09 1997-01-07 Edoga; John K. Methods for treating abdominal aortic aneurysms
US5807101A (en) * 1996-01-17 1998-09-15 Scalzo; Josephine Universal occlusal matrix
US6022336A (en) * 1996-05-20 2000-02-08 Percusurge, Inc. Catheter system for emboli containment
US20040133263A1 (en) * 1996-08-23 2004-07-08 Scimed Life Systems, Inc. Stent delivery system having stent securement apparatus
US6203558B1 (en) * 1996-08-23 2001-03-20 Scimed Life Systems, Inc. Stent delivery system having stent securement apparatus
US6068634A (en) * 1996-08-23 2000-05-30 Scimed Life Systems, Inc. Stent delivery system
US5860998A (en) * 1996-11-25 1999-01-19 C. R. Bard, Inc. Deployment device for tubular expandable prosthesis
US6056759A (en) * 1997-03-13 2000-05-02 Schneider (Usa) Inc. Fluid actuated stent delivery system
US5817101A (en) * 1997-03-13 1998-10-06 Schneider (Usa) Inc Fluid actuated stent delivery system
US6468244B1 (en) * 1997-12-19 2002-10-22 James E. Leone Catheter system having fullerenes and method
US5873907A (en) * 1998-01-27 1999-02-23 Endotex Interventional Systems, Inc. Electrolytic stent delivery system and methods of use
US20010044648A1 (en) * 1998-02-05 2001-11-22 Medtronic, Inc. Radially-expandable stent and delivery system
US6042589A (en) * 1998-03-17 2000-03-28 Medicorp, S.A. Reversible-action endoprosthesis delivery device
US6102942A (en) * 1998-03-30 2000-08-15 Endovascular Technologies, Inc. Stent/graft deployment catheter with a stent/graft attachment mechanism
US6607551B1 (en) * 1999-05-20 2003-08-19 Scimed Life Systems, Inc. Stent delivery system with nested stabilizer
US6613075B1 (en) * 1999-10-27 2003-09-02 Cordis Corporation Rapid exchange self-expanding stent delivery catheter system
US6585758B1 (en) * 1999-11-16 2003-07-01 Scimed Life Systems, Inc. Multi-section filamentary endoluminal stent
US6610087B1 (en) * 1999-11-16 2003-08-26 Scimed Life Systems, Inc. Endoluminal stent having a matched stiffness region and/or a stiffness gradient and methods for providing stent kink resistance
US6290710B1 (en) * 1999-12-29 2001-09-18 Advanced Cardiovascular Systems, Inc. Embolic protection device
US6322586B1 (en) * 2000-01-10 2001-11-27 Scimed Life Systems, Inc. Catheter tip designs and method of manufacture
US6582460B1 (en) * 2000-11-20 2003-06-24 Advanced Cardiovascular Systems, Inc. System and method for accurately deploying a stent
US6544223B1 (en) * 2001-01-05 2003-04-08 Advanced Cardiovascular Systems, Inc. Balloon catheter for delivering therapeutic agents
US6716238B2 (en) * 2001-05-10 2004-04-06 Scimed Life Systems, Inc. Stent with detachable tethers and method of using same
US20030050684A1 (en) * 2001-09-10 2003-03-13 Abrams Robert M. Internal restraint for delivery of self-expanding stents
US20030163155A1 (en) * 2002-02-22 2003-08-28 Haverkost Patrick A. Method and apparatus for deployment of an endoluminal device
US7004964B2 (en) * 2002-02-22 2006-02-28 Scimed Life Systems, Inc. Apparatus and method for deployment of an endoluminal device
US7235095B2 (en) * 2002-02-22 2007-06-26 Scimed Life Systems, Inc. Method and system for deploying multi-part endoluminal devices

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9849014B2 (en) 2002-03-12 2017-12-26 Covidien Lp Medical device delivery
US8579958B2 (en) 2002-03-12 2013-11-12 Covidien Lp Everting stent and stent delivery system
US9724221B2 (en) 2012-02-23 2017-08-08 Covidien Lp Luminal stenting
US8591566B2 (en) 2012-02-23 2013-11-26 Covidien Lp Methods and apparatus for luminal stenting
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
US9192498B2 (en) 2012-02-23 2015-11-24 Covidien Lp Luminal stenting
US11259946B2 (en) 2012-02-23 2022-03-01 Covidien Lp Luminal stenting
US9308110B2 (en) 2012-02-23 2016-04-12 Covidien Lp Luminal stenting
US10537452B2 (en) 2012-02-23 2020-01-21 Covidien Lp Luminal stenting
US9675488B2 (en) 2012-02-23 2017-06-13 Covidien Lp Luminal stenting
US9078659B2 (en) 2012-04-23 2015-07-14 Covidien Lp Delivery system with hooks for resheathability
US9949853B2 (en) 2012-04-23 2018-04-24 Covidien Lp Delivery system with hooks for resheathability
US9724222B2 (en) 2012-07-20 2017-08-08 Covidien Lp Resheathable stent delivery system
US10130500B2 (en) 2013-07-25 2018-11-20 Covidien Lp Methods and apparatus for luminal stenting
US10045867B2 (en) 2013-08-27 2018-08-14 Covidien Lp Delivery of medical devices
US11103374B2 (en) 2013-08-27 2021-08-31 Covidien Lp Delivery of medical devices
US9782186B2 (en) 2013-08-27 2017-10-10 Covidien Lp Vascular intervention system
US10092431B2 (en) 2013-08-27 2018-10-09 Covidien Lp Delivery of medical devices
US9775733B2 (en) 2013-08-27 2017-10-03 Covidien Lp Delivery of medical devices
US10265207B2 (en) 2013-08-27 2019-04-23 Covidien Lp Delivery of medical devices
US9827126B2 (en) 2013-08-27 2017-11-28 Covidien Lp Delivery of medical devices
US9474639B2 (en) 2013-08-27 2016-10-25 Covidien Lp Delivery of medical devices
US10695204B2 (en) 2013-08-27 2020-06-30 Covidien Lp Delivery of medical devices
US11076972B2 (en) 2013-08-27 2021-08-03 Covidien Lp Delivery of medical devices
WO2015196157A3 (en) * 2014-06-19 2016-02-11 Endosphere, Inc. Duodenal gastrointestinal devices and delivery mechanisms
US10945867B2 (en) 2017-01-19 2021-03-16 Covidien Lp Coupling units for medical device delivery systems
US10376396B2 (en) 2017-01-19 2019-08-13 Covidien Lp Coupling units for medical device delivery systems
US11833069B2 (en) 2017-01-19 2023-12-05 Covidien Lp Coupling units for medical device delivery systems
US11071637B2 (en) 2018-04-12 2021-07-27 Covidien Lp Medical device delivery
US10786377B2 (en) 2018-04-12 2020-09-29 Covidien Lp Medical device delivery
US11123209B2 (en) 2018-04-12 2021-09-21 Covidien Lp Medical device delivery
US11413176B2 (en) 2018-04-12 2022-08-16 Covidien Lp Medical device delivery
US11648140B2 (en) 2018-04-12 2023-05-16 Covidien Lp Medical device delivery
US11413174B2 (en) 2019-06-26 2022-08-16 Covidien Lp Core assembly for medical device delivery systems

Also Published As

Publication number Publication date
DE60312662T2 (en) 2007-11-29
US20030163155A1 (en) 2003-08-28
US7887573B2 (en) 2011-02-15
US7892272B2 (en) 2011-02-22
AU2003215288A1 (en) 2003-09-09
US20060142837A1 (en) 2006-06-29
EP1482866A1 (en) 2004-12-08
EP1482866B1 (en) 2007-03-21
DE60312662D1 (en) 2007-05-03
ATE357196T1 (en) 2007-04-15
WO2003071988A1 (en) 2003-09-04
JP4364647B2 (en) 2009-11-18
JP2005518248A (en) 2005-06-23
CA2476734A1 (en) 2003-09-04
ES2283757T3 (en) 2007-11-01
CA2476734C (en) 2010-05-11

Similar Documents

Publication Publication Date Title
US7887573B2 (en) Method and apparatus for deployment of an endoluminal device
US7235095B2 (en) Method and system for deploying multi-part endoluminal devices
US7331985B2 (en) Apparatus and method for deployment of an endoluminal device
US6926732B2 (en) Stent delivery device and method
JP3441090B2 (en) Bifurcated endovascular graft and device for deploying the graft
US6808534B1 (en) Collapsible jacket guard
US7854758B2 (en) Exclusion of ascending/descending aorta and/or aortic arch aneurysm
JP4284002B2 (en) Stent delivery system to prevent twist and method of loading the same
EP1086664B1 (en) Apparatus for delivering an endoluminal prosthesis
EP1796583B1 (en) Device for delivering an endovascular stent-graft having a logitudinally unsupported portion
JP3761967B2 (en) sheath
US7527645B2 (en) Delivery system for endoluminal implant
AU692072B2 (en) Endoprosthesis stent/graft deployment system
US7393357B2 (en) Endovascular stent graft
EP1894545B1 (en) Multiple in vivo implant delivery device
WO1999043379A1 (en) Delivery system and method for deployment and endovascular assembly of multi-stage stent graft
US20120191110A1 (en) Endovascular positioning and delivery device
MXPA98003109A (en) Catheter and method for an endoprote supply system

Legal Events

Date Code Title Description
AS Assignment

Owner name: ACACIA RESEARCH GROUP LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:030694/0461

Effective date: 20121220

AS Assignment

Owner name: LIFESHIELD SCIENCES LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACACIA RESEARCH GROUP LLC;REEL/FRAME:030740/0225

Effective date: 20130515

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION